Dr. Mahdavi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1640 Newport Blvd
Ste 400
Costa Mesa, CA 92627Phone+1 949-999-2400Fax+1 949-999-2405
Education & Training
- The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1978 - 1979
- Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Hematology and Medical Oncology, 1976 - 1977
- Loyola University Medical Center/Trinity-Mercy ChicagoResidency, Internal Medicine, 1974 - 1976
- Grant Hospital of ChicagoResidency, Family Medicine, 1973 - 1974
- Grant Hospital of ChicagoInternship, Transitional Year, 1972 - 1973
- Tehran University of Medical Sciences School of MedicineClass of 1969
Certifications & Licensure
- IL State Medical License 1974 - Present
- CA State Medical License 1979 - 2026
- OH State Medical License 1977 - 1979
- American Board of Internal Medicine Internal Medicine
- National Board of Physicians and Surgeons Hematology
- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
Awards, Honors, & Recognition
- Fellow (FACP) American College of Physicians, 1995
Publications & Presentations
PubMed
- 3 citationsThe integration of high-dose chemotherapy and biotherapy: initial 5-year experience with autologous bone marrow transplantation in a comprehensive community cancer cen...Robert O. Dillman, Neil M. Barth, Khosrow Mahdavi, Louis A. VanderMolen, Shankar K. Nayak
Cancer Biotherapy. 1995-01-01 - 19 citationsTreatment of kidney cancer with autologous tumor cell vaccines of short-term cell lines derived from renal cell carcinoma.Robert O. Dillman, Neil M. Barth, Louis A. VanderMolen, David H. Garfield, Cristina de Leon
Cancer Biotherapy & Radiopharmaceuticals. 2001-02-01 - 12 citationsThe feasibility of using short-term cultures of ovarian cancer cells for use as autologous tumor cell vaccines as adjuvant treatment of advanced ovarian cancer.Robert O. Dillman, Shankar K. Nayak, John V. Brown, Khosrow Mahdavi, Linda D. Beutel
Cancer Biotherapy & Radiopharmaceuticals. 1999-12-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: